Douglas Denham
Family Medicine · San Antonio, TXNPI 1467533893
Payments from drug & device makers
Across 11,810 payments — averaging $5804.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$18.7M
- Modernatx, Inc.$16.2M
- Astrazeneca UK Limited$4.5M
- Eli Lilly$3.9M
- Janssen Research & Development, LLC$3.6M
- Biontech SE$3.1M
- plus $18.5M from 39 others
Across 19 payments — averaging $4615.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$81K
- Pfizer$6K
- Novo Nordisk AS$121
- Gilead$78
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$68,546,786 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.
Other family medicine in San Antonio
- George AtieeSan Antonio$19.9M
- Leonel ReyesSan Antonio$4.3M
- Brian MacgillivraySan Antonio$3.2M
- Juan GarzaSan Antonio$2.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.